Literature DB >> 171359

Letter: Additional findings in galactokinase deficiency.

R Gitzelmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171359     DOI: 10.1016/s0022-3476(75)80937-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

Review 1.  Innovative therapy for Classic Galactosemia - tale of two HTS.

Authors:  M Tang; S I Odejinmi; H Vankayalapati; K J Wierenga; K Lai
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

2.  Molecular and biochemical characterization of human galactokinase and its small molecule inhibitors.

Authors:  M Tang; K Wierenga; L J Elsas; K Lai
Journal:  Chem Biol Interact       Date:  2010-08-07       Impact factor: 5.192

3.  High-throughput screening for human galactokinase inhibitors.

Authors:  Klaas J Wierenga; Kent Lai; Peter Buchwald; Manshu Tang
Journal:  J Biomol Screen       Date:  2008-05-19

Review 4.  Galactose toxicity in animals.

Authors:  Kent Lai; Louis J Elsas; Klaas J Wierenga
Journal:  IUBMB Life       Date:  2009-11       Impact factor: 3.885

5.  ARHI: A new target of galactose toxicity in Classic Galactosemia.

Authors:  K Lai; M Tang; X Yin; H Klapper; K Wierenga; Lj Elsas
Journal:  Biosci Hypotheses       Date:  2008

6.  Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model.

Authors:  Tatiana I Slepak; Manshu Tang; Vladlen Z Slepak; Kent Lai
Journal:  Mol Genet Metab       Date:  2007-07-20       Impact factor: 4.797

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.